AstraZeneca Bets Big on China with Record $15B Investment in 2026
AstraZeneca announces a $15 billion investment in China during UK PM Starmer’s visit, signaling strong confidence in the country’s healthcare innovation.
PharmaTrends
Read More
🚀 Chinese Biotech Breakthrough: New Cancer Drug Surpasses Global Leader 🌟
A Chinese biotech firm’s new cancer drug, Ivonescimab, outperformed Keytruda in trials, signaling a major leap in global healthcare innovation. 🌍💊